• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型人类免疫缺陷病毒gag基因中接头插入突变对在细菌中表达的病毒蛋白酶激活的影响

Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria.

作者信息

Luban J, Lee C, Goff S P

机构信息

Department of Medicine, College of Physicians and Surgeons, Columbia University, New York 10032.

出版信息

J Virol. 1993 Jun;67(6):3630-4. doi: 10.1128/JVI.67.6.3630-3634.1993.

DOI:10.1128/JVI.67.6.3630-3634.1993
PMID:8497070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC237714/
Abstract

We have expressed the human immunodeficiency virus type 1 (HIV-1) protease (PR) in bacteria as a Gag-PR polyprotein (J. Luban and S.P. Goff, J. Virol. 65:3203-3212, 1991). The protein displays enzymatic activity, cleaving the Gag polyprotein precursor Pr55gag to the expected products. The PR enzyme is only active as a dimer, and we hypothesized that PR activation might be used as an indicator of polyprotein multimerization. We constructed 25 linker insertion mutations throughout gag and assessed the PR activity of mutant Gag-PR polyproteins by the appearance of Gag cleavage products in bacterial lysates. All mutant constructs produced stable protein in bacteria. PR activity of the majority of the Gag-PR mutants was indistinguishable from that of the wild type. Six mutants, one with an insertion in the matrix (MA), four with insertions in the capsid (CA), and one with insertions in the nucleocapsid (NC), globally disrupted polyprotein processing. When PR was provided in trans on a separate plasmid, the Gag proteins were cleaved with wild-type efficiency. These results suggest that the gag mutations identified as disruptive of polyprotein processing did not conceal the scissile bonds of the polyprotein. Rather, the mutations prevented PR activation in the context of a Gag-PR polyprotein, perhaps by preventing polyprotein dimerization.

摘要

我们已在细菌中表达了1型人类免疫缺陷病毒(HIV-1)蛋白酶(PR),其形式为Gag-PR多聚蛋白(J. Luban和S.P. Goff,《病毒学杂志》65:3203 - 3212,1991年)。该蛋白具有酶活性,可将Gag多聚蛋白前体Pr55gag切割成预期产物。PR酶仅作为二聚体具有活性,我们推测PR激活可能用作多聚蛋白多聚化的指标。我们在gag基因上构建了25个连接子插入突变,并通过细菌裂解物中Gag切割产物的出现来评估突变型Gag-PR多聚蛋白的PR活性。所有突变体构建体在细菌中都产生了稳定的蛋白质。大多数Gag-PR突变体的PR活性与野生型无差异。六个突变体,一个在基质(MA)中有插入,四个在衣壳(CA)中有插入,一个在核衣壳(NC)中有插入,全面破坏了多聚蛋白的加工过程。当在单独的质粒上反式提供PR时,可以以野生型效率切割Gag蛋白。这些结果表明,被鉴定为破坏多聚蛋白加工的gag突变并未掩盖多聚蛋白的可裂解键。相反,这些突变可能通过阻止多聚蛋白二聚化,从而在Gag-PR多聚蛋白的背景下阻止了PR激活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93d7/237714/000b44152865/jvirol00027-0685-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93d7/237714/44824f4a50f7/jvirol00027-0683-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93d7/237714/000b44152865/jvirol00027-0685-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93d7/237714/44824f4a50f7/jvirol00027-0683-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93d7/237714/000b44152865/jvirol00027-0685-a.jpg

相似文献

1
Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria.1型人类免疫缺陷病毒gag基因中接头插入突变对在细菌中表达的病毒蛋白酶激活的影响
J Virol. 1993 Jun;67(6):3630-4. doi: 10.1128/JVI.67.6.3630-3634.1993.
2
Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1.延伸核衣壳蛋白是从1型人类免疫缺陷病毒的Gag-Pol前体中切割而来的。
J Gen Virol. 2001 Mar;82(Pt 3):581-590. doi: 10.1099/0022-1317-82-3-581.
3
Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active.1型人类免疫缺陷病毒的gag蛋白酶融合蛋白具有酶活性。
J Virol. 1992 Nov;66(11):6781-3. doi: 10.1128/JVI.66.11.6781-6783.1992.
4
Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.人类免疫缺陷病毒Vpr-蛋白酶与Vpx-蛋白酶融合蛋白的蛋白水解活性
Virology. 1996 May 1;219(1):307-13. doi: 10.1006/viro.1996.0253.
5
Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.在重组杆状病毒感染细胞中表达的人类免疫缺陷病毒1型Gag前体插入突变体的表型特征
J Virol. 1994 Jan;68(1):111-22. doi: 10.1128/JVI.68.1.111-122.1994.
6
Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain.来自一种在蛋白酶(PR)结构域N端带有阻断突变的前体的新型人类免疫缺陷病毒1型蛋白酶蛋白的蛋白水解活性。
J Virol. 1994 Jan;68(1):240-50. doi: 10.1128/JVI.68.1.240-250.1994.
7
Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.在基于细胞的表达系统中所证实的猫免疫缺陷病毒/人免疫缺陷病毒突变蛋白酶的gag多蛋白切割特异性改变。
J Virol. 2006 Aug;80(16):7832-43. doi: 10.1128/JVI.00374-06.
8
Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.1型人类免疫缺陷病毒蛋白酶基因的突变会影响病毒颗粒的释放和稳定性。
Virology. 1993 Jun;194(2):843-50. doi: 10.1006/viro.1993.1328.
9
Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.劳氏肉瘤病毒Gag多聚蛋白加工过程的改变及其对病毒粒子形成的影响。
J Virol. 1997 Mar;71(3):2083-91. doi: 10.1128/JVI.71.3.2083-2091.1997.
10
The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.人类免疫缺陷病毒1型的非肉豆蔻酰化Pr160gag-pol多聚蛋白与Pr55gag相互作用,并被整合到病毒样颗粒中。
J Virol. 1992 Nov;66(11):6304-13. doi: 10.1128/JVI.66.11.6304-6313.1992.

引用本文的文献

1
Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.1型人类免疫缺陷病毒Gag多聚蛋白多聚化需要核衣壳结构域和RNA,并由衣壳二聚体界面和基质蛋白的碱性区域促进。
J Virol. 1999 Oct;73(10):8527-40. doi: 10.1128/JVI.73.10.8527-8540.1999.
2
Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.对能够进行病毒样颗粒组装和释放的最小人类免疫缺陷病毒1型gag编码序列的分析。
J Virol. 1998 Oct;72(10):7950-9. doi: 10.1128/JVI.72.10.7950-7959.1998.
3

本文引用的文献

1
Improved plasmid vectors with a thermoinducible expression and temperature-regulated runaway replication.具有热诱导表达和温度调节失控复制功能的改良质粒载体。
Gene. 1983 Apr;22(1):103-13. doi: 10.1016/0378-1119(83)90069-0.
2
A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.莫洛尼鼠白血病病毒pol基因5'端的缺失突变会阻断gag和pol多聚蛋白的蛋白水解加工过程。
J Virol. 1985 Mar;53(3):899-907. doi: 10.1128/JVI.53.3.899-907.1985.
3
Extracellular creatine regulates creatine transport in rat and human muscle cells.
Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
功能性逆转录酶(RT)和整合酶(IN)独立于Gag/Pol前体蛋白整合到HIV-1颗粒中。
EMBO J. 1997 Aug 15;16(16):5113-22. doi: 10.1093/emboj/16.16.5113.
4
The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle.Gag在1型人类免疫缺陷病毒病毒体形态发生及病毒生命周期早期步骤中的作用。
J Virol. 1996 Dec;70(12):8645-52. doi: 10.1128/JVI.70.12.8645-8652.1996.
5
Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization.人类免疫缺陷病毒1型Gag多聚蛋白与亲环素A的结合由衣壳的中央区域介导,且需要Gag二聚化。
J Virol. 1996 Jul;70(7):4299-310. doi: 10.1128/JVI.70.7.4299-4310.1996.
6
Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.亲环素A是1型人类免疫缺陷病毒生命周期中逆转录开始前早期阶段所必需的。
J Virol. 1996 Jun;70(6):3551-60. doi: 10.1128/JVI.70.6.3551-3560.1996.
7
Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.在重组杆状病毒感染细胞中表达的人类免疫缺陷病毒1型Gag前体插入突变体的表型特征
J Virol. 1994 Jan;68(1):111-22. doi: 10.1128/JVI.68.1.111-122.1994.
8
Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.人类免疫缺陷病毒1型RNA中顺式作用包装信号的突变分析。
J Virol. 1994 Jun;68(6):3784-93. doi: 10.1128/JVI.68.6.3784-3793.1994.
9
Specificity and sequence requirements for interactions between various retroviral Gag proteins.各种逆转录病毒Gag蛋白之间相互作用的特异性和序列要求。
J Virol. 1994 Aug;68(8):5300-5. doi: 10.1128/JVI.68.8.5300-5305.1994.
10
Functional domains of the capsid protein of human immunodeficiency virus type 1.1型人类免疫缺陷病毒衣壳蛋白的功能结构域
J Virol. 1994 Dec;68(12):8180-7. doi: 10.1128/JVI.68.12.8180-8187.1994.
细胞外肌酸调节大鼠和人类肌肉细胞中的肌酸转运。
Proc Natl Acad Sci U S A. 1988 Feb;85(3):807-11. doi: 10.1073/pnas.85.3.807.
4
Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor.在大肠杆菌中表达的人类免疫缺陷病毒蛋白酶表现出gag前体的自身加工和特异性成熟。
Proc Natl Acad Sci U S A. 1987 Dec;84(24):8903-6. doi: 10.1073/pnas.84.24.8903.
5
Active human immunodeficiency virus protease is required for viral infectivity.活跃的人类免疫缺陷病毒蛋白酶是病毒感染性所必需的。
Proc Natl Acad Sci U S A. 1988 Jul;85(13):4686-90. doi: 10.1073/pnas.85.13.4686.
6
An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity.在大肠杆菌中表达的一种11千道尔顿形式的人类免疫缺陷病毒蛋白酶就足以具备酶活性。
Proc Natl Acad Sci U S A. 1988 Apr;85(8):2449-53. doi: 10.1073/pnas.85.8.2449.
7
HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins.HIV-1蛋白酶对肽段切割的特异性足以对gag和pol多聚蛋白进行加工处理。
Biochem Biophys Res Commun. 1988 Oct 14;156(1):297-303. doi: 10.1016/s0006-291x(88)80839-8.
8
Activity of avian retroviral protease expressed in Escherichia coli.在大肠杆菌中表达的禽逆转录病毒蛋白酶的活性。
J Virol. 1988 Aug;62(8):2696-700. doi: 10.1128/JVI.62.8.2696-2700.1988.
9
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.衣壳前体加工和肉豆蔻酰化在1型人类免疫缺陷病毒形态发生和感染性中的作用。
Proc Natl Acad Sci U S A. 1989 Aug;86(15):5781-5. doi: 10.1073/pnas.86.15.5781.
10
Identification of protein intermediates in the processing of the p55 HIV-1 gag precursor in cells infected with recombinant vaccinia virus.在感染重组痘苗病毒的细胞中鉴定 p55 HIV-1 gag 前体加工过程中的蛋白质中间体。
J Biol Chem. 1989 May 25;264(15):8459-62.